COVID-19 vaccination in autoimmune disease (COVAD) survey protocol

Parikshit Sen, Latika Gupta, James B. Lilleker, Vishwesh Aggarwal, Sinan Kardes, Marcin Milchert, Tamer Gheita, Babur Salim, Tsvetelina Velikova, Abraham Edgar Gracia-Ramos, Ioannis Parodis, Albert Selva O'Callaghan, Elena Nikiphorou, Ai Lyn Tan, Lorenzo Cavagna, Miguel A. Saavedra, Samuel Katsuyuki Shinjo, Nelly Ziade, Johannes Knitza, Masataka KuwanaGiovanni Cagnotto, Arvind Nune, Oliver Distler, Hector Chinoy, Vikas Aggarwal, Rohit Aggarwal, COVAD Study Group

Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskriftPeer review

1 Citering (SciVal)

Sammanfattning

The coronavirus disease-2019 (COVID-19) pandemic continues to be a cause of unprecedented global morbidity and mortality. Whilst COVID-19 vaccination has emerged as the only tangible solution to reducing poor clinical outcomes, vaccine hesitancy continues to be an obstacle to achieving high levels of vaccine uptake. This represents particular risk to patients with autoimmune diseases, a group already at increased risk of hospitalization and poor clinical outcomes related to COVID-19 infection. Whilst there is a paucity of long-term safety and efficacy data of COVID-19 vaccination in patients with autoimmune diseases, the current evidence strongly suggests that the benefits of vaccination outweigh the risks of adverse effects and disease flares. Herein, we report the protocol of the COVID-19 Vaccination in Autoimmune Diseases (COVAD) study, an ongoing international collaborative study involving 29 countries and over 110 investigators.

Originalspråkengelska
Sidor (från-till)23-29
Antal sidor7
TidskriftRheumatology International
Volym42
Utgåva1
DOI
StatusPublished - 2022

Ämnesklassifikation (UKÄ)

  • Folkhälsovetenskap, global hälsa, socialmedicin och epidemiologi

Fingeravtryck

Utforska forskningsämnen för ”COVID-19 vaccination in autoimmune disease (COVAD) survey protocol”. Tillsammans bildar de ett unikt fingeravtryck.

Citera det här